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Abstract
Background: Multiple studies suggest creatine mediates anti-oxidant activity in addition to its established role in cellular
energy metabolism. The functional significance for the heart has yet to be established, but antioxidant activity could
contribute to the cardioprotective effect of creatine in ischaemia/reperfusion injury.
Objectives: To determine whether intracellular creatine levels influence responses to acute reactive oxygen species (ROS)
exposure in the intact beating heart. We hypothesised that mice with elevated creatine due to over-expression of the
creatine transporter (CrT-OE) would be relatively protected, while mice with creatine-deficiency (GAMT KO) would fare
worse.
Methods and Results: CrT-OE mice were pre-selected for creatine levels 20–100% above wild-type using in vivo 1H–MRS.
Hearts were perfused in isovolumic Langendorff mode and cardiac function monitored throughout. After 20 min
equilibration, hearts were perfused with either H2O2 0.5 mM (30 min), or the anti-neoplastic drug doxorubicin 15 mM
(100 min). Protein carbonylation, creatine kinase isoenzyme activities and phospho-PKCd expression were quantified in
perfused hearts as markers of oxidative damage and apoptotic signalling. Wild-type hearts responded to ROS challenge
with a profound decline in contractile function that was ameliorated by co-administration of catalase or dexrazoxane as
positive controls. In contrast, the functional deterioration in CrT-OE and GAMT KO hearts was indistinguishable from wild-
type controls, as was the extent of oxidative damage and apoptosis. Exogenous creatine supplementation also failed to
protect hearts from doxorubicin-induced dysfunction.
Conclusions: Intracellular creatine levels do not influence the response to acute ROS challenge in the intact beating heart,
arguing against creatine exerting (patho-)physiologically relevant anti-oxidant activity.
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Introduction
The canonical role of creatine (Cr) is the transfer and buffering
of chemical energy via the creatine kinase (CK) reaction, linking
ATP production to ATP utilization in cells with high energy
demand [1]. However, multiple studies have attributed creatine
with both direct and indirect anti-oxidant activity [2–6]. For
example, there is in vitro evidence for direct scavenging of free
radicals [5], protection of mitochondrial DNA from oxidative
damage [4]; and up-regulation of enzymes involved in intracellular
oxidative defences [7]. Patients with creatine deficiency syndrome
are reported to have increased oxidative stress and ROS-induced
apoptotic cell loss [8], while creatine supplementation in senescent
mice improved neurobehavioral outcomes and prolonged median
survival with a trend towards lower reactive oxygen species (ROS)
[9]. More specifically in the heart, our own work has shown that
elevating intracellular creatine via over-expression of the creatine
transporter (CrT) reduces myocardial stunning and ischaemia/
reperfusion injury [10]. However, the extent to which anti-oxidant
effects may contribute to cardioprotection has not been fully
elucidated.
One way to assess this is to challenge intact hearts with known
sources of oxidative stress in order to determine whether
intracellular creatine levels influence the acute response. For
example, hydrogen peroxide (H2O2) is a relatively stable,
membrane diffusible, non-radical species of ROS [11,12] and
the exogenous administration of H2O2 has been reported to cause
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a degree of cardiac dysfunction similar to ischemia [13].
Cardiotoxicity predominately arises from the generation of
reactive oxygen intermediates such as hydroxyl radicals and
singlet oxygen leading to peroxidation of membrane phospholip-
ids, altered membrane permeability, and irreversible loss of cell
integrity [14]. Additional mechanisms of toxicity may be related to
direct inhibition of glycolytic ATP generation [15], or to redox
regulation of regulatory kinases and sarcomeric proteins [12].
A more clinically relevant source of oxidative stress are the
antineoplastic anthracycline drugs (e.g. doxorubicin). These are
widely used and effective, but dosing is constrained by cardiotoxic
side effects which can lead to heart failure [16–18]. Doxorubicin is
known to accumulate in mitochondrial membranes of cardiomy-
ocytes [17], where a number of complex interactions may occur
leading to the generation of superoxide anion, hydrogen peroxide
and subsequently hydroxyl radicals via a Fenton reaction with
iron. The result is oxidation of key proteins with mitochondrial
proteins particularly vulnerable, ultimately leading to ATP
depletion [16,18].
Modulating intracellular creatine levels in the heart is not
straightforward since cardiomyocytes cannot synthesize creatine
[19] and increased dietary creatine does not result in elevated
tissue levels [20]. To circumvent this we have previously created
mice that constitutively over-express myocardial CrT (CrT-OE)
[21]. For the purpose of studying creatine-free hearts, we used
mice with knockout of the key biosynthetic enzyme, guanidinoa-
cetate N-methyltransferase (GAMT KO), which have a whole
body creatine-deficiency as previously described [22,23].
Thus the objective of this study was to determine whether the
anti-oxidant effects attributed to creatine in vitro have physiolog-
ical significance to the intact heart. To address this we measured
the effect of acute oxidative stress caused by H2O2 or doxorubicin
on cardiac function in Langendorff perfused mouse hearts.
Specifically, we hypothesized that GAMT KO mice with zero
creatine in the heart would be more susceptible to ROS-mediated
dysfunction, and conversely, that CrT-OE hearts with elevated
intracellular creatine would be protected.
Materials and Methods
Animal Husbandry
Creatine transporter overexpressing and GAMT KO mice were
bred in-house and genotyped as previously described [21–23].
Both strains are congenic to C57BL/6J and wild-type littermates
(WT) were used as controls. Additional experiments made use of
C57BL/6J male mice purchased from Harlan, UK. Mice were
housed in specific pathogen-free cages with a 12 h light-dark cycle,
controlled humidity and temperature (20–22uC), fed Teklad
Global 16% Protein Rodent Diet (naturally creatine-free) and
water ad libitum. From 6 weeks of age, GAMT KO mice were
housed per genotype to prevent creatine ingestion via copropha-
gia. All experiments were approved by institutional ethical review
committee and conform to the UK Animals (Scientific Procedures)
Act 1986 incorporating European Directive 2010/63/EU.
In vivo 1H magnetic resonance spectroscopy (1H-MRS)
Myocardial creatine [Cr] was measured non-invasively on a 9.4
T (400 MHz) MR system (Agilent Technologies) using a
quadrature-driven birdcage resonator (Rapid Biomedical). CrT-
OE mice were anaesthetized with isoflurane and maintained at
1.5–2% in oxygen. Cardiac metabolite signals from a 2 ml voxel,
placed in the interventricular septum, were acquired using a
double-gated, double spin-echo sequence. Creatine signal was
normalized to the water signal and total [Cr] estimated from the
average creatine/water ratio using a calibration curve as reported
previously [24].
Heart Perfusions
Mice were anaesthetised by intra-peritoneal injection of
pentobarbitone 140 mg/kg. Beating hearts were rapidly excised,
cannulated and perfused in the isovolumic Langendorff mode at
80 mmHg perfusion pressure, 37uC with Krebs-Henseleit (KH)
buffer continuously gassed with 95% O2/5% CO2 (pH 7.4)
containing (in mM): NaCl 120, KCl 4.7, MgSO4.7H2O 1.2,
NaHCO3 25, KH2PO4 1.2, CaCl2.H2O 1.8, glucose 11. Cardiac
function was assessed using a fluid-filled cling film balloon inserted
via the mitral valve into the left ventricle (LV), and connected via
a line to a pressure transducer (Memscap) and a Powerlab/8 SP
system (AD Instruments). The intraventricular volume was
adjusted to achieve an initial LV diastolic pressure of 10–
15 mmHg [23]. Functional parameters were averaged for ,80
cardiac cycles at 5 min perfusion intervals. Left ventricular
developed pressure (LVDP) was calculated as the difference
between systolic (SP) and diastolic pressures (DP) [25]. Rate
pressure product (RPP) was determined as the product of heart
rate and LVDP. At the end of each perfusion, hearts were freeze
clamped using Wollenberger tongs, cooled in liquid nitrogen and
stored at –80uC until further analysis.
Perfusion protocols
Pilot Study 1: H2O2 dose finding. The effect of H2O2 on
ex-vivo function was tested in hearts from C57BL/6J mice at the
following concentrations: 200 mM, 100 mM, 50 mM, 5 mM, 1 mM
and 0.5 mM (n= 3 for each). Stability of H2O2 in KH buffer was
checked spectrophotometrically using Amplex red hydrogen
peroxide/peroxidase assay kit (Invitrogen) and was found to be
within 4% and 9% of starting values after 30 min and 60 min
perfusion, respectively. H2O2 KH buffer was therefore always
made fresh immediately prior to the perfusion experiment.
Perfusion with the H2O2 scavenger, catalase (150 U/ml, Sigma
Aldrich), was used as a positive control (n = 4 per group).
Following 20 min equilibration: group 1 was perfused with
0.5 mM H2O2 for 30 min; group 2 received 20 min pre-treatment
with 150 U/ml catalase.
Pilot Study 2: Doxorubicin dose finding. Doxorubicin
hydrochloride (Dox) (Sigma Aldrich) stock (10 mg/vial) was
reconstituted in Milipore-filtered water to a concentration of
10 mM and kept in frozen aliquots away from light until use.
A dose of 15 mM administered over 80 min was chosen from
the literature since this has been shown to cause a significant
reduction in perfused rat heart function [26]. This dose was
confirmed experimentally in perfused C57BL/6J hearts (n = 3)
with and without 20 min pre-treatment with the iron-chelator
dexrazoxane 300 mM as a positive control (n = 5) (Cardioxane,
Novartis).
Hydrogen peroxide-induced oxidative stress. After
20 min of functional equilibration, hearts from the following
groups were perfused for 30 minutes with 0.5 mM H2O2
containing KH buffer:
(i) GAMT KO and WT (n= 4 per group, female, 46 weeks).
(ii) CrT-OE mice pre-selected for moderately elevated cardiac
creatine levels (mean 11467 nmol/mg protein, 72 weeks,
n = 7, female) with age-matched WT (mean creatine
6565 nmol/mg protein, 72 weeks, n = 4, female).
Myocardial Creatine and Oxidative Stress
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Doxorubicin-induced oxidative stress. After 20 min of
functional equilibration, hearts from these groups were perfused
for 100 minutes with 15 mM Dox containing KH buffer:
(i) GAMT KO (n= 8, male, 54 weeks) with age-matched WT
controls (n = 5, 3 female/2 male).
(ii) CrT-OE mice pre-selected for moderately elevated cardiac
creatine levels (mean 11466 nmol/mg protein, 82 weeks,
n = 6 female) with age and sex matched WT controls
(creatine 6865 nmol/mg protein, n = 4).
(iii) C57BL/6J mouse hearts perfused as above (n = 5 male) and
with addition of 500 mM creatine monohydrate (Sigma
Aldrich) to the perfusate throughout (n = 8, male).
Biochemical Analysis
ROS induced cardiotoxicity has been linked to the direct
oxidative structural and functional modification of all myocardial
CK isoforms, with further specific injury of cardiac mitochondrial
isoform of CK (MtCK) [27,28]. Total creatine kinase (Total CK)
and individual isoform activities: mitochondrial CK (mito-CK),
myofibrilar (MM-CK) and minor cytosolic isoforms (MB-CK and
BB-CK) were measured as described before [29].
Protein Expression Analysis
Sample preparation. Snap-frozen hearts were ground and
suspended in 350 ml of lysis buffer containing 2% SDS, 50 mM
Tris pH 7.5, 150 mmol/l NaCl, 1 mM DTT, protease and
phosphatase inhibitor cocktail (cOmplete Ultra EDTA-free and
PhoSTOP respectively, Roche). Samples were homogenized using
a polytron homogenizer prior to centrifugation at 4uC for
5 minutes at 13,000 rpm. The supernatants were stored at –
80uC until protein content was determined by the bicinchoninic
acid method (BCA) [30].
Carbonylation. 20 mg from each sample was used to
derivatize to single-strength 2,4 dinitro phenyl hydrazine (DNPH,
Camlab Chemicals) in 100% trifluoroacetic acid (TFA, Thermo
Scientific) as previously described [31,32]. The derivatization
reaction was stopped by neutralization with 2 M TRIS/30%
glycerol. Samples were separated on a pre-cast 12% SDS gel
(Thermo Scientific) at 100 V for 90 minutes at room temperature
in HEPES buffer (Thermo Scientific) followed by transferring of
proteins onto a PVDF membrane (GE Healthcare). Membranes
were blocked in 3% BSA in PBS/Tween-20 (0.1%) for 1 hr at
room temperature, followed by incubation using a 1u anti-DNPH
antibody at 1:150 (Millipore) for 1 hr at room temperature.
DNPH epitopes were detected by a secondary anti-mouse IgG
HRP-conjugated antibody (Millipore). Immunoblotted proteins
were detected by chemiluminescence using the ECL Advance Kit
(GE Healthcare). To confirm equal protein loading, gels were
stained using Coomassie blue dye (Sigma Aldrich).
To test the sensitivity of the carbonylation assay, a positive
control of oxidised bovine serum albumin was prepared as
described in the Millipore OxyBlot manual.
p-PKC d. 20 mg of protein extracted in the presence of
protease and phosphatase inhibitors was separated on a 12%
precast SDS gel (Thermo Scientific). This was followed by a
protein transfer to a PVDF membrane, blocking (5% BSA in
1xTBS, 0.01% Tween-20) and an overnight incubation at 4uC in
primary antibody (1:1000) against Thr505 phosphorylated PKC d
(Cell Signaling Technologies). HRP-conjugated secondary anti-
rabbit IgG antibody (Promega) was incubated at 1:20,000 for 1 hr
at room temperature prior to visualization with the ECL advance
chemiluminescence kit (GE Healthcare). As a positive control,
MCF-7 breast cancer cells were treated with 0.2 mg/ml Dox for 4
hours in the absence of foetal bovine serum (FBS).
Quantification - membranes were stripped and re-probed using
an anti a-actinin antibody (Sigma Aldrich) as previously described
[30]. Densitometry was performed using a FluoChem 8800 (Alpha
Innotech Corporation) and normalised to a actinin.
Statistical Analysis
The results are presented as mean6SEM. Statistical signifi-
cance of functional parameters were assessed using Graphpad
Prism software v 5.04 by two-way analysis of variance with
Bonferroni’s correction for multiple comparisons. For protein
markers of oxidative stress, one-way ANOVA with Bonferroni’s
correction was used to compare selected groups. Wild-types were
compared with genetically-modified mice at baseline, and after
Dox and H2O2 exposure; and exposed hearts were compared to
baseline values for the same genotype. Differences were considered
significant when P,0.05.
Results
Pilot Study 1: H2O2 dose finding
Perfusion of C57BL/6 mouse hearts with H2O2 (0.5–200 mM)
resulted in functional arrest in a dose-dependent manner
(Figure 1A), with concentrations .5 mM inducing functional
failure and total irreversible cardiac arrest within 561 minutes
(Figure 1A). A dose of 0.5 mM H2O2 was therefore chosen for all
subsequent perfusions since the deleterious effects were observable
over the time course of perfusion, without being too rapid to detect
differences in responses between groups. Furthermore, catalase
treatment fully inhibited the effect of 0.5 mM H2O2 on LVDP
indicating that positive modulation of experimental outcome was
achievable at this dose (Figure 1B).
Pilot Study 2: Doxorubicin dose finding
A doxorubicin concentration of 15 mM resulted in gradual and
significant functional decline (,70%) during 70 min perfusion.
Inclusion of dexrazoxane 300 mM in the perfusion buffer as a
positive control significantly delayed the functional decline in
response to doxorubicin (Figure 1C).
Creatine does not protect against acute oxidative stress
in the intact heart
There were no significant differences in heart or body weight
between CrT-OE and WT controls, while GAMT KO mice
exhibited lower heart weight compared to controls, commensurate
with a lower body weight as described previously [22] (Table 1). In
all experiments, isolated perfused hearts were allowed to
equilibrate for 20 min.
There were no significant differences in LV functional
parameters prior to oxidative stress challenge in any of our
experimental groups when compared to their corresponding WT
controls (t = 0 time-point in Figures 2 and 3). Therefore intracel-
lular creatine content had no effect on ex-vivo baseline cardiac
function.
Perfusion with H2O2 led to a decline in all LV functional
parameters that were virtually indistinguishable between GAMT
KO and WT hearts (Figure 2A). A similar response was observed
for CrT-OE hearts versus WT controls (Figure 2B), with the
exception of significant differences at single-time points for end-
diastolic pressure (t = 30 min, Figure 2B) and rate pressure
product (t = 5 min, Figure 2B). However, these effects were
unsustained and inconsistent, and therefore unlikely to have
physiological relevance. Similarly, doxorubicin-induced oxidative
Myocardial Creatine and Oxidative Stress
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e109021
stress had comparable effect on cardiac (dys) function of both
GAMT KO hearts (Figure 3A) and CrT-OE (Figure 3B) versus
their matching WT controls.
To determine whether creatine location was important, i.e.
extracellular versus intracellular, we administered exogenous
creatine monohydrate in the perfusate of doxorubicin-treated
C57BL/6 hearts. Exogenous creatine had no effect on baseline ex-
vivo cardiac function, nor did it ameliorate functional decline
compared to doxorubicin-treated hearts alone (Figure 4).
Markers of oxidative stress and apoptosis
Creatine kinase enzyme activity. At the cellular level, the
activities of total CK and the individual CK isoforms (mitoCK,
CK-MM, CK-MB, CK-BB) as markers of intracellular oxidative
stress, were not different when compared to their WT controls. A
similar response was observed in all genotypes (GAMT KO and
CrT-OE) and both oxidative stress agents used (Figure 5).
Protein carbonylation. The ability to detect changes in
protein carbonylation was validated by assaying known quantities
of non-oxidised and oxidised BSA. Oxidised BSA displayed
significantly higher levels of carbonylation when compared to
equal amounts (20 mg) of untreated BSA (P,0.001; Figure 6A).
Levels of protein carbonylation were quantified in mouse heart
tissue at baseline and following acute oxidative stress in
Langendorff perfused hearts (see Figure 6B, D for representative
blots, C–E for quantification). Protein carbonylation was not
significantly different at baseline between CrT-OE and WT or
GAMT KO and WT, but was elevated in all groups as expected
following exposure to either H2O2 or Dox (Figure 6C & E; One-
way ANOVA, P,0.001 compared to baseline for both). Crucially,
there was no significant difference in the extent of carbonylation
between CrT-OE and GAMT KO compared to their respective
controls. This confirms on a molecular level that the level of
oxidative stress experienced by these hearts was not influenced by
intracellular creatine levels.
p-PKC d. The expression of phosphorylated PKC d was
assessed as a marker of apoptotic pathway activation in the same
samples as above (representative blot shown in Figure 6G, H).
Phospho-PKC d levels were similar between CrT-OE and WT at
baseline and did not significantly change following exposure to
either Dox or H2O2 (One-way ANOVA, P=0.16; Figure 6G). In
GAMT KOmice, p-PKC d was not different at baseline, however,
was significantly elevated with exposure to Dox or H2O2, but to an
equal extent for both WT and KO hearts (P=0.0324 versus
baseline; Figure 6H). Doxorubicin-treated MCF-7 cells, used as
positive control, displayed increased p-PKC d levels versus
untreated (Figure 6F).
Discussion
This is the first study to examine whether intracellular creatine
levels influence the response to acute oxidative stress in the intact
beating heart. Here we show that two different ROS sources,
H2O2 and doxorubicin, both cause terminal decline in ex vivo
mouse cardiac function.
This functional deterioration was unaltered in hearts with
intracellular creatine,75% higher than controls, or in hearts with
a complete deficiency of creatine. This was confirmed at the
molecular level by measurement of carbonylation, indicating that
exposure of proteins to oxidative damage was not influenced by
creatine levels. This argues against creatine having significant anti-
oxidant activity in the intact heart under acute pathological
conditions.
Figure 1. Graded effect of varying doses of H2O2 in Krebs-Henseleit buffer on functional arrest time (time for LVDP to reduce to
0 mmHg) in isolated perfused mouse hearts (n =3/group) (A). (B) Protective effect of catalase against H2O2–induced function deterioration.
*P,0.01 catalase treated (n = 4) vs. H2O2 treated group (n = 4). (C) Protective effect of dexrazoxane on ex-vivo cardiac function against doxorubicin
(Dox) challenge. *P,0.05 vs. dexrazoxane treated hearts (n = 5); Dox (n = 3). LVDP-left ventricular developed pressure. Data mean6S.E.M. P value is for
the effect of the genotype by ANOVA with Bonferroni’s correction.
doi:10.1371/journal.pone.0109021.g001
Table 1. Morphometric parameters of mice used in the study.
CrT-WT
(n=8F)
CrT-OE
(n =13; 13F)
GAMT WT
(n=9; 7F+2 M)
GAMT KO
(n=12; 4F+8 M)
Age (weeks) 8563 8262 5064 5064
Body weight (g) 3363 3063 2764 1861*
Wet heart weight (LV+RV) (mg) 150610 150610 200620 100610*
Wet heart weight/tibia length (mg/cm) 8767 8667 111610 7865*
Wet heart weight/body weight (mg/g) 4.660.3 4.660.2 4.760.5 5.860.2
LV- left ventricular, RV- right ventricular, All values are mean6SEM.
*P,0.05 versus wild-type for that strain by Student’s t-test.
doi:10.1371/journal.pone.0109021.t001
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Figure 2. Effect of 0.5 mM H2O2 on cardiac function during 30 min exposure in isolated perfused GAMT KO hearts and wild-type
(WT) controls (A). GAMT KO (n= 4) with the age and sex matched corresponding wild-type (GAMT WT) mice (n = 4; female). (B) Effect of 0.5 mM
H2O2 on cardiac function during 30 min exposure in isolated perfused Cr-T overexpressing (CrT-OE) hearts (n = 7; 7 female) and age matched wild-
type (CrT-WT) controls (n = 4; female). RPP- rate pressure product. *P,0.05 vs WT. Data mean6S.E.M. P value is for the effect of the genotype by
ANOVA with Bonferroni’s correction.
doi:10.1371/journal.pone.0109021.g002
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Figure 3. Effect of doxorubicin on cardiac function during 100 min perfusion in: (A) isolated perfused GAMT KO hearts and wild-
type (WT) controls. GAMT KO (n= 8; male); WT (n = 5; 3 female+2 male) (B) isolated perfused CrT overexpressing hearts (CrT-OE) and wild-type (WT)
controls. CrT-OE (n = 6; female); WT (n = 4; female); RPP- rate pressure product. P,0.05 vs WT. Data mean6S.E.M. P value is for the effect of the
genotype by ANOVA with Bonferroni’s correction.
doi:10.1371/journal.pone.0109021.g003
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These findings provide insight into our previous report in CrT-
OE mice, which showed that similarly elevated levels of
myocardial creatine protected against ischaemia/reperfusion
injury both in vivo and ex vivo [10]. Since I/R injury is associated
with a burst of ROS upon reperfusion, then the anti-oxidant
effects attributed to creatine could account, in part, for the
protective mechanism. Our current work supports the view that
the cardio-protective effects of creatine against I/R injury are
unrelated to antioxidant activity and are therefore most likely
attributable to improved cardiac energetics and protection against
mPTP opening as previously described [33]. These protective
mechanisms in CrT-OE mice include increased energy reserve in
the form of PCr/ATP ratio and glycogen storage, as well as
increased energy release from ATP hydrolysis. Since these positive
Figure 4. Effect of exogenous creatine supplementation (500 mmol/L) on cardiac function during 70 min doxorubicin (Dox)
exposure (n=8, C57BL/6J; male). RPP- rate pressure product. Data mean6S.E.M.
doi:10.1371/journal.pone.0109021.g004
Figure 5. Effect of acute oxidative stress on myocardial creatine kinase (CK) isoform activities: mitochondrial (Mito-CK), myofibrilar
(CK-MM), minor cytosolic isoforms (CK-MB, CK-BB): Effect of 0.5 mMH2O2 on CK isoenzyme activities of (A) GAMTWT (n=3) and KO
(n=6) (B) CrT-WT (n=3) and OE (n=4). Effect of doxorubicin on CK isoenzyme activities of (C) GAMT WT (n= 6) and KO (n= 7) and (D) CrT-WT
(n = 4) and OE (n = 5). Enzyme activities given in IU/mg protein normalized to WT values. Data mean6S.E.M. Comparison with wild-type for that strain
by Student’s t-test.
doi:10.1371/journal.pone.0109021.g005
Myocardial Creatine and Oxidative Stress
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Figure 6. Analysis of phosphorylated PKC d and carbonylation protein profile in response to acute oxidative stress. (A) Oxidized
bovine serum albumin (BSA) control demonstrating sensitivity of the assay to detect differences in protein carbonylation. ***P,0.0001 **P=0.008 ns:
non-significant. Profile of total carbonylation levels in DNPH-derivatised mouse LV tissue using immunoblotting and probing vs DNPH.
Representative blots of (B) Wild-type (WT), CrT-OE (OE) and (D) GAMT KO (KO) and wild-type (WT). (C) Expression of ROS-induced protein damage in
lysates of CrT-OE vs WT (E) GAMT KO vs WT at baseline, after exposure to doxorubicin hydrochloride (Dox) and H2O2. (F) Representative blot of
doxorubicin-treated MCF-7 cells used as positive control displayed increased p-PKC d levels (Dox–FBS) versus untreated cells (Dox+FBS, –FBS).
Phosphorylated PKC d band was obtained only in the FBS pre-starved cells that were subsequently exposed to Dox. (G) Expression of p-PKC d in CrT-
OE vs WT and (H) GAMT KO vs WT hearts at baseline, after Dox or H2O2 treatment [figure includes representative p-PKC d western blot images for
sample groups as above]. Data mean6S.E.M. CrT-OE (n = 5) WT (n = 6) GAMT KO (n= 6) WT (n = 5). *P,0.05, **P,0.01, ***P,0.001 for comparison
with baseline values for same genotype by one-way ANOVA with Bonferroni correction.
doi:10.1371/journal.pone.0109021.g006
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energetic adaptations did not confer protection against acute
oxidative stress, suggests that energetic imbalance is not the major
cause of dysfunction under these hyper-acute conditions.
One possibility is that the experimental conditions were too
harsh to observe a protective effect of creatine in the current study
and that subtle effects may have been missed. Certainly, both
ROS sources had a rapid and profound effect resulting in
irreversible decline and complete cardiac arrest within 30 min for
H2O2 perfusion and 100 min for doxorubicin. Nevertheless, we
demonstrated via the use of positive controls that this pathology
could be beneficially modified. For example, catalase converts two
molecules of H2O2 to O2 and H2O and was effective in completely
protecting against H2O2 –induced damage.
Similarly, addition of the iron-chelator dexrazoxane altered the
time-course of doxorubicin-induced dysfunction, presumably by
preventing the formation of hydroxyl radicals via the iron-
dependent Fenton reaction. It should also be noted that the
concentration of 0.5 mM H2O2 is within the range of estimated
exposure levels for cardiomyocytes under pathophysiological
conditions, e.g. ischaemia/reperfusion [11,12]. Likewise, the
concentration of doxorubicin we used is similar to the clinically
relevant dose observed in plasma of patients after bolus injection
[34]. We therefore believe that these are meaningful experimental
models and that a robust anti-oxidant effect of creatine would have
been readily detectable.
Previous reports have demonstrated cardioprotective effects of
exogenously administered phosphocreatine (PCr) in H2O2 per-
fused rat hearts [35]. Since creatine is inter-converted to PCr via
the creatine kinase reaction, it is worth considering why our
findings are in apparent disagreement. The key difference is that
PCr must exert any protective effect extracellularly, since it is too
polar to cross the plasma membrane and is not a substrate for
uptake via the creatine transporter. That we failed to observe
protection from addition of exogenous creatine suggests that the
phosphoryl group has functional significance [35]. Exogenous PCr
has been shown to directly bind to phospholipid-containing
membranes, altering structure and conformation of membrane
phospholipids thus protecting membranes from permeabilization
by doxorubicin-induced oxidative stress [36,37].
Limitations
Although GAMT KO mice are entirely creatine-free, they do
accumulate the creatine precursor guanidinoacetate (GA) to
relatively high levels, including in the heart. GA can participate
in the CK reaction, but the kinetics are insufficient to compensate
for the energetic deficit in GAMT KO hearts [23,38]. However, if
GA and creatine both share similar anti-oxidant activity, this could
explain why GAMT KO hearts were similarly susceptible to ROS
mediated dysfunction.
Nothing is known about the role of GA in myocardial oxidative
stress, however, it has previously been shown that GA adminis-
tration to rat striatum reduces antioxidant capacity [39], arguing
against a compensatory protective role from GA accumulation.
In our study we used mature mice ($1 year) which are more
representative of the age of patients with heart disease [40],
patients with anthracycline induced cardiomyopathy [41] and in
line with current recommendations to include older mice in pre-
clinical studies [42]. However, for pragmatic reasons this
necessitated the use of both sexes, and we were careful to age-
and sex- match groups throughout the study. Unfortunately, in
one experimental group (doxorubicin-treated GAMTWT) we had
insufficient mice of the appropriate genotype .1 year old and
therefore had to use mixed gender (n = 3 females n= 2 males)
rather than an all male group. Cleary this is non-ideal, however,
we firmly believe it is highly unlikely to affect the outcome of the
study for a number of reasons. Firstly, there was no divergence in
response when individual traces were plotted together. Further-
more, in contrast to other mammalian species, female mice have
age-associated mitochondrial superoxide generation comparable
to males [43]. In addition, although estrogen can protect female
mice from ischaemia/reperfusion injury [44], our three female
mice are unlikely to benefit from estrogen-mediated cardioprotec-
tion since estrogen levels decline by 75% between 6 and 18 months
[45]. Lastly, our study used retrograde ex-vivo Langendorff
perfusion with crystalloid Krebs-Henseleit buffer and is therefore
lacking in circulating hormones that may exert gender specific
cardioprotection in-vivo.
Specifically, in our study we do not rule out that creatine may
have a protective role against the gradual functional decline
observed in chronic in vivo models of doxorubicin toxicity. There
is a large body of evidence describing impaired cardiac energetics
in response to doxorubicin dosing, including decreased PCr and
ATP levels, inactivation of mitochondrial respiratory enzymes and
altered substrate utilisation (see [46] for comprehensive review).
Recent findings also show reduced creatine kinase (CK) activity
[47] and impaired creatine uptake capacity due to down-
regulation of the creatine transporter [48]. Most notably, genetic
over-expression of the muscle isoform of CK in heart improved
cardiac function and survival in a chronic mouse model of
doxorubicin toxicity [49]. A reduction in plasma markers of
cytotoxicity has also been observed with oral creatine supplemen-
tation in rats, although the effect on cardiac function was not
reported [50]. Clearly, it remains possible that increasing
intracellular creatine levels might protect against anthracycline
toxicity in long-term experiments via energetic mechanisms.
Conclusion
Using two genetic models of chronically altered myocardial
creatine (supra-physiological elevation and zero-creatine) we have
demonstrated that intracellular creatine content does not influence
the detrimental effects of acute oxidative stress on cardiac function.
This argues against creatine possessing significant antioxidant
activity under acute pathological conditions in the intact beating
heart.
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